Cholinesterase Research

This collection of 10 papers includes original as well as review articles focused on the cholinesterase structural aspects, drug design and development of novel cholinesterase ligands, but also contains papers focused on the natural compounds and their effect on the cholinergic system and unexplored...

Full description

Saved in:
Bibliographic Details
Other Authors: Korabecny, Jan (Editor), Soukup, Ondrej (Editor)
Format: Book Chapter
Published: Basel, Switzerland MDPI - Multidisciplinary Digital Publishing Institute 2021
Subjects:
Online Access:Get Fullteks
DOAB: description of the publication
Tags: Add Tag
No Tags, Be the first to tag this record!
LEADER 03159naaaa2200925uu 4500
001 doab_20_500_12854_76707
005 20220111
020 |a books978-3-0365-1797-1 
020 |a 9783036517988 
020 |a 9783036517971 
024 7 |a 10.3390/books978-3-0365-1797-1  |c doi 
041 0 |a English 
042 |a dc 
072 7 |a M  |2 bicssc 
100 1 |a Korabecny, Jan  |4 edt 
700 1 |a Soukup, Ondrej  |4 edt 
700 1 |a Korabecny, Jan  |4 oth 
700 1 |a Soukup, Ondrej  |4 oth 
245 1 0 |a Cholinesterase Research 
260 |a Basel, Switzerland  |b MDPI - Multidisciplinary Digital Publishing Institute  |c 2021 
300 |a 1 electronic resource (223 p.) 
506 0 |a Open Access  |2 star  |f Unrestricted online access 
520 |a This collection of 10 papers includes original as well as review articles focused on the cholinesterase structural aspects, drug design and development of novel cholinesterase ligands, but also contains papers focused on the natural compounds and their effect on the cholinergic system and unexplored effects of donepezil. 
540 |a Creative Commons  |f https://creativecommons.org/licenses/by/4.0/  |2 cc  |4 https://creativecommons.org/licenses/by/4.0/ 
546 |a English 
650 7 |a Medicine  |2 bicssc 
653 |a Amaryllidaceae 
653 |a Narcissus pseudonarcissus cv. Carlton 
653 |a alkaloids 
653 |a carltonine A-C 
653 |a Alzheimer's disease 
653 |a butyrylcholinesterase 
653 |a docking studies 
653 |a organophosphorus nerve agents 
653 |a oxime 
653 |a cholinesterase 
653 |a reactivation 
653 |a ventilation 
653 |a pharmacodynamics 
653 |a blood-brain barrier crossing 
653 |a acetylcholinesterase inhibitors 
653 |a bone healing 
653 |a osseointegration 
653 |a donepezil 
653 |a hemostasis 
653 |a acetylcholinesterase inhibitor 
653 |a dementia 
653 |a zebrafish 
653 |a behavior 
653 |a Alzheimer disease 
653 |a antioxidants 
653 |a butyrylcholinesterase inhibitors 
653 |a molecular modelling 
653 |a nutraceuticals 
653 |a phytochemicals 
653 |a acetylcholinesterase 
653 |a slow-binding inhibition 
653 |a transition state analog 
653 |a organophosphorus 
653 |a osmotic stress 
653 |a neutron scattering 
653 |a molecular dynamics 
653 |a MD simulations 
653 |a fluorene 
653 |a in vitro 
653 |a in silico 
653 |a multi-target directed ligands 
653 |a N-methyl-d-aspartate receptor 
653 |a molecular modeling 
653 |a reactivators 
653 |a reactivation process 
653 |a organophosphates 
653 |a docking 
653 |a hydrolysis 
653 |a molecular recognition 
653 |a catalysis 
653 |a inhibition 
653 |a n/a 
856 4 0 |a www.oapen.org  |u https://mdpi.com/books/pdfview/book/4156  |7 0  |z Get Fullteks 
856 4 0 |a www.oapen.org  |u https://directory.doabooks.org/handle/20.500.12854/76707  |7 0  |z DOAB: description of the publication